| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Medical Microbiology, Vol 44, Issue 3 203-210, Copyright © 1996 by Society for General Microbiology
JOURNAL ARTICLE |
T. L. Pitt, M. E. Kaufmann, P. S. Patel, L. C. Benge, S. Gaskin and D. M. Livermore
Laboratory of Hospital Infection, Central Public Health Laboratory, London, UK.
The spread of Burkholderia cepacia among cystic fibrosis (CF) patients in the UK prompted an investigation into whether an epidemic strain was responsible. A total of 366 B. cepacia isolates from 178 CF patients in 17 centres was examined by ribotyping and pulsed-field gel electrophoresis (PFGE). Associations were also sought between antibiotic resistance and strain type. More than 50 ribotype patterns were found but one, termed ribotype 1, was identified from 68 patients in eight centres. One centre had a single patient with this type while, in others, most or all patients harboured this organism. Small clusters of apparent cross-colonisation within centres were also evident for some other ribotypes. PFGE confirmed that ribotype 1 isolates were genetically similar. Ribotype 1 isolates were not markedly more resistant to antimicrobial agents than were other isolates, and the MICs of individual antibiotics were no more tightly clustered for ribotype 1 isolates than for others. Most isolates were resistant to ciprofloxacin, amikacin, gentamicin, tobramycin, carbenicillin, cefuroxime, cefotaxime, imipenem, biapenem, chloramphenicol, tetracycline, trimethoprim and sulphamethoxazole, but > or = 77% were susceptible to ceftazidime, piperacillin, piperacillin/ tazobactam and meropenem. We conclude that numerous strains of B. cepacia colonise CF patients in the UK and Ireland but that one epidemic strain has spread in at least eight centres. Isolates of this strain appear homogenous in total genomic profile but very variable in antibiotic susceptibility.
This article has been cited by other articles:
|
|
 |
|
  A. De Soyza, A. Silipo, R. Lanzetta, J. R. Govan, and A. Molinaro Review: Chemical and biological features of Burkholderia cepacia complex lipopolysaccharides Innate Immunity, June 1, 2008; 14(3): 127 - 144. [Abstract] [PDF]
|
|
|
|
 |
|
 A Smyth and J S Elborn Exacerbations in cystic fibrosis: 3 {middle dot} Management Thorax, February 1, 2008; 63(2): 180 - 184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. W. Whitby, T. M. VanWagoner, J. M. Springer, D. J. Morton, T. W. Seale, and T. L. Stull Burkholderia cenocepacia utilizes ferritin as an iron source J. Med. Microbiol., June 1, 2006; 55(6): 661 - 668. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. W. Whitby, T. M. VanWagoner, A. A. Taylor, T. W. Seale, D. J. Morton, J. J. LiPuma, and T. L. Stull Identification of an RTX determinant of Burkholderia cenocepacia J2315 by subtractive hybridization J. Med. Microbiol., January 1, 2006; 55(1): 11 - 21. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Campana, G. Taccetti, N. Ravenni, F. Favari, L. Cariani, A. Sciacca, D. Savoia, A. Collura, E. Fiscarelli, G. De Intinis, et al. Transmission of Burkholderia cepacia Complex: Evidence for New Epidemic Clones Infecting Cystic Fibrosis Patients in Italy J. Clin. Microbiol., October 1, 2005; 43(10): 5136 - 5142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Turton, M. E. Kaufmann, N. Mustafa, S. Kawa, F. E. Clode, and T. L. Pitt Molecular Comparison of Isolates of Burkholderia multivorans from Patients with Cystic Fibrosis in the United Kingdom J. Clin. Microbiol., December 1, 2003; 41(12): 5750 - 5754. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Vinion-Dubiel and J. B. Goldberg Review: Lipopolysaccharide of Burkholderia cepacia complex Innate Immunity, August 1, 2003; 9(4): 201 - 213. [Abstract] [PDF]
|
|
|
|
|
|
L. Liu, T. Spilker, T. Coenye, and J. J. LiPuma Identification by Subtractive Hybridization of a Novel Insertion Element Specific for Two Widespread Burkholderia cepacia Genomovar III Strains J. Clin. Microbiol., June 1, 2003; 41(6): 2471 - 2476. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Langley, D. T. Kenna, P. Vandamme, R. Ure, and J. R. W. Govan Lysogeny and bacteriophage host range within the Burkholderia cepacia complex J. Med. Microbiol., June 1, 2003; 52(6): 483 - 490. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Sajjan, L. Liu, A. Lu, T. Spilker, J. Forstner, and J. J. LiPuma Lack of cable pili expression by cblA-containing Burkholderia cepacia complex Microbiology, November 1, 2002; 148(11): 3477 - 3484. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. J. Inglis, L. O'Reilly, N. Foster, A. Clair, and J. Sampson Comparison of Rapid, Automated Ribotyping and DNA Macrorestriction Analysis of Burkholderia pseudomallei J. Clin. Microbiol., September 1, 2002; 40(9): 3198 - 3203. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Nzula, P. Vandamme, and J. R. W. Govan Influence of taxonomic status on the in vitro antimicrobial susceptibility of the Burkholderia cepacia complex J. Antimicrob. Chemother., August 1, 2002; 50(2): 265 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Heath, K. Hohneker, C. Carriker, K. Smith, J. Routh, J. J. LiPuma, R. M. Aris, D. Weber, and P. H. Gilligan Six-Year Molecular Analysis of Burkholderia cepacia Complex Isolates among Cystic Fibrosis Patients at a Referral Center for Lung Transplantation J. Clin. Microbiol., April 1, 2002; 40(4): 1188 - 1193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Agodi, E. Mahenthiralingam, M. Barchitta, V. Giannino, A. Sciacca, and S. Stefani Burkholderia cepacia Complex Infection in Italian Patients with Cystic Fibrosis: Prevalence, Epidemiology, and Genomovar Status J. Clin. Microbiol., August 1, 2001; 39(8): 2891 - 2896. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. LiPUMA, T. SPILKER, L. H. GILL, P. W. CAMPBELL III, L. LIU, and E. MAHENTHIRALINGAM Disproportionate Distribution of Burkholderia cepacia Complex Species and Transmissibility Markers in Cystic Fibrosis Am. J. Respir. Crit. Care Med., July 1, 2001; 164(1): 92 - 96. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. I. Daneshvar, D. G. Hollis, A. G. Steigerwalt, A. M. Whitney, L. Spangler, M. P. Douglas, J. G. Jordan, J. P. MacGregor, B. C. Hill, F. C. Tenover, et al. Assignment of CDC Weak Oxidizer Group 2 (WO-2) to the Genus Pandoraea and Characterization of Three New Pandoraea Genomospecies J. Clin. Microbiol., May 1, 2001; 39(5): 1819 - 1826. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. P. Lynch III Hospital-Acquired Pneumonia : Risk Factors, Microbiology, and Treatment Chest, February 1, 2001; 119(2_suppl): 373S - 384S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. E. Clode, M. E. Kaufmann, H. Malnick, and T. L. Pitt Distribution of Genes Encoding Putative Transmissibility Factors among Epidemic and Nonepidemic Strains of Burkholderia cepacia from Cystic Fibrosis Patients in the United Kingdom J. Clin. Microbiol., May 1, 2000; 38(5): 1763 - 1766. [Abstract] [Full Text]
|
|
|
|
|
|
S. Brisse, C. M. Verduin, D. Milatovic, A. Fluit, J. Verhoef, S. Laevens, P. Vandamme, B. Tümmler, H. A. Verbrugh, and A. van Belkum Distinguishing Species of the Burkholderia cepacia Complex and Burkholderia gladioli by Automated Ribotyping J. Clin. Microbiol., May 1, 2000; 38(5): 1876 - 1884. [Abstract] [Full Text]
|
|
|
|
 |
|
 U. S. Sajjan, F. A. Sylvester, and J. F. Forstner Cable-Piliated Burkholderia cepacia Binds to Cytokeratin 13 of Epithelial Cells Infect. Immun., April 1, 2000; 68(4): 1787 - 1795. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. W. Martin and C. D. Mohr Invasion and Intracellular Survival of Burkholderia cepacia Infect. Immun., January 1, 2000; 68(1): 24 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Segonds, T. Heulin, N. Marty, and G. Chabanon Differentiation of Burkholderia Species by PCR-Restriction Fragment Length Polymorphism Analysis of the 16S rRNA Gene and Application to Cystic Fibrosis Isolates J. Clin. Microbiol., July 1, 1999; 37(7): 2201 - 2208. [Abstract] [Full Text]
|
|
|
|
|
|
F. E. CLODE, L. A. METHERELL, and T. L. PITT NOSOCOMIAL ACQUISITION OF BURKHOLDERIA GLADIOLI IN PATIENTS WITH CYSTIC FIBROSIS Am. J. Respir. Crit. Care Med., July 1, 1999; 160(1): 374 - 375. [Full Text]
|
|
|
|
 |
|
 S. Bonacorsi, F. Fitoussi, S. Lhopital, and E. Bingen Comparative In Vitro Activities of Meropenem, Imipenem, Temocillin, Piperacillin, and Ceftazidime in Combination with Tobramycin, Rifampin, or Ciprofloxacin against Burkholderia cepacia Isolates from Patients with Cystic Fibrosis Antimicrob. Agents Chemother., February 1, 1999; 43(2): 213 - 217. [Abstract] [Full Text]
|
|
|
|
|
|
M. L. Hutchison, I. R. Poxton, and J. R. W. Govan Burkholderia cepacia Produces a Hemolysin That Is Capable of Inducing Apoptosis and Degranulation of Mammalian Phagocytes Infect. Immun., May 1, 1998; 66(5): 2033 - 2039. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M J Ledson, M J Gallagher, and M J Walshaw Chronic Burkholderia cepacia bronchiectasis in a non-cystic fibrosis individual Thorax, May 1, 1998; 53(5): 430 - 432. [Abstract] [Full Text]
|
|
|
|
|
|
M J Ledson, M J Gallagher, J E Corkill, C A Hart, and M J Walshaw Cross infection between cystic fibrosis patients colonised with Burkholderia cepacia Thorax, May 1, 1998; 53(5): 432 - 436. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |
